NIH-funded research NIH-funded research

Digital alcohol-reduction aid for young cancer survivors

Official title: Development of a Digital Alcohol Reduction Intervention for Adolescent and Young Adult Cancer Survivors: Preparation for an Optimization Trial

Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-11444090 · Data updated 2026-11-12

A technology-based program helps adolescents and young adults who have survived cancer reduce risky drinking in a way that fits with the challenges of post-treatment life.

More Cancer Survivors research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHenry Ford Health + Michigan State University Health Sciences
NIH-funded
Lab location1 site (East Lansing, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$309,874
NIH project number1R34CA318298-01
Project IDNIH-11444090 on NIH RePORTER

Who could benefit from this research

Could help

AYAs aged roughly 15–29 who have survived cancer and drink alcohol at levels above recommended guidelines.

Less likely to help

AYAs who do not drink or who may not engage with digital health tools may see limited benefit.

What this research studies

This project builds on a short, tech-based plan previously tested for AYAs who survived cancer. It aims to adapt and simplify the program so clinics can use it in real-world cancer care without overburdening staff. The approach would include digital self-monitoring and targeted coaching to address cancer-related stressors that influence drinking, such as fear of recurrence and financial worries. The team will test which parts of the intervention are essential to achieving meaningful reductions in alcohol use. The work is designed to translate a workable, scalable solution into routine survivorship care.

Why it matters

Potential benefit: If successful, the program could help AYA cancer survivors drink less, improving quality of life and reducing health risks.

How similar studies have gone: Prior feasibility work showed the approach is acceptable and feasible, but scalability and component optimization are still being tested.

Where this research is happening

  • Henry Ford Health + Michigan State University Health Sciences
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Lauckner, Carolyn — Henry Ford Health + Michigan State University Health Sciences
  • Study coordinator: Lauckner, Carolyn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.